Profile
David Phillips worked as an Executive Director at Arovella Therapeutics Ltd.
from 2021 to 2022.
Prior to that, he was a Senior Vice President of Sales & Marketing at Charles River Discovery Research Services UK Ltd.
He also worked as a Managing Partner at GSK Equity Investments Ltd.
and as a Chief Business Officer at both Pulmagen Therapeutics (Synergy) Ltd.
and The Automation Partnership (Cambridge) Ltd.
Mr. Phillips completed his undergraduate degree at the University of London.
Former positions of David Phillips
| Companies | Position | End |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Director/Board Member | 2022-01-13 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Corporate Officer/Principal | - |
The Automation Partnership (Cambridge) Ltd.
 The Automation Partnership (Cambridge) Ltd. BiotechnologyHealth Technology The Automation Partnership Cambridge Ltd. engages in the development, manufacture, and distribution of automated systems for the life science industries. The company was founded on June 2, 1993 and is headquartered in Royston, the United Kingdom. | Corporate Officer/Principal | - |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Corporate Officer/Principal | - |
Charles River Discovery Research Services UK Ltd.
 Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Sales & Marketing | - |
Training of David Phillips
| University of London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AROVELLA THERAPEUTICS LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Charles River Discovery Research Services UK Ltd.
Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Commercial Services |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
The Automation Partnership (Cambridge) Ltd.
The Automation Partnership (Cambridge) Ltd. BiotechnologyHealth Technology The Automation Partnership Cambridge Ltd. engages in the development, manufacture, and distribution of automated systems for the life science industries. The company was founded on June 2, 1993 and is headquartered in Royston, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- David Phillips
